
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norov... HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.16 | 9.4674556213 | 1.69 | 1.86 | 1.65 | 303479 | 1.79108709 | CS |
4 | 0.24 | 14.9068322981 | 1.61 | 1.86 | 1.34 | 307605 | 1.57227312 | CS |
12 | -0.11 | -5.61224489796 | 1.96 | 2 | 1.34 | 206299 | 1.68806612 | CS |
26 | 0.02 | 1.09289617486 | 1.83 | 2.15 | 1.34 | 219654 | 1.83427103 | CS |
52 | -10.55 | -85.0806451613 | 12.4 | 16.305 | 1.34 | 437196 | 2.71344953 | CS |
156 | -16.91 | -90.1385927505 | 18.76 | 24.42 | 1.34 | 215171 | 6.70381657 | CS |
260 | -16.91 | -90.1385927505 | 18.76 | 24.42 | 1.34 | 215171 | 6.70381657 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions